You searched for "drug"

228 results found

Mucormycosis: In conversation with Dr Deepak Haldipur and Dr Aditya Moorthy

COVID-19 has ravaged the world in the past 18 months. The second wave in many countries was deadlier than the first. Mucormycosis, infamously labelled ‘the black fungus’ has affected some countries, such as India, in epidemic proportions within this COVID...

Development of the iAudiometer™

Why the iAudiometer™? We have developed six versions of a new software called iAudiometer™ that performs an array of different audiometric tests using an iPad with standard transducers (TDH-39 headphones, B-71 BC, aural domes, or inserts) (Figure 1; Table 1)....

What’s new in the cochlea?

Prof Furness in this article rounds up the steps and leaps being made by the scientific community to develop therapies to support, rejuvenate and / or replace the cochlear structures. David’s electron microscope images of the cochlear structures are world...

Aspirin desensitisation for aspirin-exacerbated respiratory disease (AERD)

In this article, the authors describe the importance of identifying aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis refractory to standard medical treatment. This can then open the door to considering aspirin desensitisation treatment which, in their hands, has proven...

The role of macrolide antibiotics in chronic rhinosinusitis

The use of long-term antibiotics in the treatment of chronic rhinosinusitis is a contentious issue, not only because of the increasing problem with antibiotic resistance but also because of the potential cardiac risks, including sudden death. In this article, Anders...

What’s new in auditory processing?

Auditory processing disorder (APD) has had a controversial history, stemming mainly from lack of scientific rigor and accepted clinical definition. That situation is now changing. Driven by the huge number of people with unaddressed listening difficulties, basic discoveries in neuroscience,...

Developing medical devices for children: opportunities and challenges

The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...

Rhinology: what does the future hold?

David Kennedy surveys the past, the present and the future of rhinology practice and research. An evolution of understanding in rhinology The dramatic growth of clinical and translational research within the field of rhinology in recent years is illustrated by...

Microneedles enable inner ear precision medicine

Developing safe, reliable and efficient ways to deliver therapeutics into the cochlea is a key challenge. In this article, the authors share their work to develop microneedles to address this challenge. The era of precision medicine of the inner ear...

Neuromod establishes US subsidiary and appoints Eric Timm as US Chief Executive Officer

Neuromod Devices Ltd, the Irish medical device company which specialises in neuromodulation technologies, has announced the establishment of Neuromod USA Inc., a subsidiary headquartered in Oak Brook, Illinois.

BIOHIT HealthCare is exhibiting at the BSI congress 2022

BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.

IFOS World Master Course in Hearing Rehabilitation in Collaboration with the GCC Symposium Otology 2019

Report by: Dr Priya Carling, AuD, Director and Consultant Audiologist IFOS in collaboration with SFORL, the French Otolaryngology Society, and together with GCC Otology, held a three-day master course on hearing rehabilitation in Dubai in March. The course was aimed...